Industry News
Atsena Therapeutics Secures $150 Million Series C Funding to Advance Ocular Gene Therapy Pipeline

Atsena Therapeutics has successfully closed an oversubscribed $150 million Series C financing round ...

read more
Atsena Therapeutics Secures $150 Million Series C Funding to Advance Ocular Gene Therapy Pipeline
April 04, 2025
FDA Issues Complete Response Letter to Aldeyra Therapeutics for Reproxalap NDA Resubmission

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra T...

read more
FDA Issues Complete Response Letter to Aldeyra Therapeutics for Reproxalap NDA Resubmission
April 04, 2025
Prevent Blindness Declares April as Women’s Eye Health and Safety Month

Prevent Blindness, a leading nonprofit organization dedicated to eye health, has officially designat...

read more
Prevent Blindness Declares April as Women’s Eye Health and Safety Month
April 03, 2025
Labtician Ophthalmics Launches Lab TRIACTIV Artificial Tears

Labtician Ophthalmics has officially announced the commercial launch of Lab TRIACTIV, a next-generat...

read more
Labtician Ophthalmics Launches Lab TRIACTIV Artificial Tears
April 03, 2025
Zeiss Medical Technology Receives NMPA Approval for ILM-Blue in China

Zeiss Medical Technology has announced that ILM-Blue, an internal limiting membrane (ILM) dye develo...

read more
Zeiss Medical Technology Receives NMPA Approval for ILM-Blue in China
April 02, 2025
OKYO Pharma Reports Positive Long-Term Stability Data for Urcosimod in Neuropathic Corneal Pain

OKYO Pharma has announced encouraging data on the long-term stability of urcosimod (formerly OK-101)...

read more
OKYO Pharma Reports Positive Long-Term Stability Data for Urcosimod in Neuropathic Corneal Pain
April 02, 2025
Sydnexis Receives Positive CHMP Opinion for SYD-101 to Treat Pediatric Myopia in Europe

Sydnexis has announced a significant milestone with the European Medicines Agency’s (EMA) Committee ...

read more
Sydnexis Receives Positive CHMP Opinion for SYD-101 to Treat Pediatric Myopia in Europe
April 02, 2025
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease

Alcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech compan...

read more
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease
March 28, 2025
Bausch + Lomb Issues Voluntary Recall of Select enVista Intraocular Lenses

Bausch + Lomb has initiated a voluntary recall of specific intraocular lenses (IOLs) from its enVist...

read more
Bausch + Lomb Issues Voluntary Recall of Select enVista Intraocular Lenses
March 28, 2025
Pantheon Vision Partners with Eyedeal Medical to Develop Bioengineered Corneal Implant

Pantheon Vision has announced a strategic partnership with Eyedeal Medical to co-develop a bioengine...

read more
Pantheon Vision Partners with Eyedeal Medical to Develop Bioengineered Corneal Implant
March 28, 2025
More